StudyManager, Inc., a healthcare IT company and creator of StudyManager clinical trial management software (CTMS), today announced the release of Reveal version 3.1, expanding the recruitment, financial, and reporting capabilities of its clinical trial management software (CTMS) for sites and hospitals.
Expanded Business Management and Productivity Tools for Research Sites
Reveal 3.1 allows research organizations to centralize study information, organize research activities, and increase recruitment and financial performance.
Strong Market Response to Reveal and Personalized Service
StudyManager has seen a 40% increase in Reveal sales in the second half of 2010, compared to the first half of the year. Growth is expected to accelerate further in 2011, as StudyManager pairs its Reveal cloud solution with an on-premises option and continues to expand features and services. With Reveal, each customer gets a dedicated trainer who builds a training plan around the customer’s needs and objectives.
Improving the Research Site "Bottom Line"
Reveal is built on the feedback and experience of StudyManager's customers, and the company's nearly 20 years in the field. Then, Reveal's decision support tools can have a big impact on the bottom line, helping sites negotiate more favorable contracts, make enrollment course corrections, and ensure they get paid for all study activity.
Reveal features focus on helping sites centralize study information, and:
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Real-World Data Show 99% Efficacy for Apretude in HIV Prevention with High Adherence, Reduced Stigma
October 16th 2024Real-world data presented at IDWeek 2024 show Apretude (cabotegravir long-acting) is more than 99% effective in preventing HIV infection, with high adherence rates, reduced stigma and anxiety, and broad acceptability.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.